National cohort study examined events in Medicare beneficiaries.
Read More »Dr. Richard Bergman, Parts 5 & 6 – The Diabetes and Obesity Research Institute, Blood Pressure Vs. Blood Glucose
To wrap up this series, we present the final two installments of the conversation between Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman. In part 5, Steve learns more about the institute founded and led by Dr. Bergman at Cedars-Sinai. In part 6, Steve asks what is more important — blood pressure or blood glucose levels?
Read More »Dr. Richard Bergman, Part 4 – Diabetes, Altitude and the Role of Kidneys in Research
Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman discuss his ADA presentations — the relationship between diabetes and altitude, and the role of kidneys in diabetes research. Steve also asks why the degredation of insulin in the liver is important in the pathogenesis of diabetes. Dr. Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.
Read More »Controlled Type 2 Patients Being Over Treated
Nearly half of patients with stable A1c, who do not use insulin, found to be unnecessarily tested three to four times a year.
Read More »Victoza Vs. SGLT-2 inhibitor for Better BG Control
Safety, efficacy of these new classes of diabetic medication require more detailed investigation.
Read More »Structured Personal Diabetes Care Reduced Mortality Rates in Women, Not Men
New study showed women accept disease, implement disease management more easily.
Read More »Fact: Downloading of Data From Our Apps, Meters and CGM’s is Great. But How Do We Use It?
According to Jenise Wong, MD, PhD, of the University of California San Francisco, who reported the results at an oral session at the joint meeting of the Endocrine Society and the International Congress on Endocrinology, “We need to really equip patients with better tools and education on how to use their data.” David Kliff responds: Now some would argue that this is why IDM is needed, as it not only collects and transmits data, but it provides for an easy interaction between the patient and their healthcare team; that it’s the healthcare team that’s doing all the data analytics; that all the patient needs to do is collect the data; and that this focus on data can actually make a patient tune out even when they are getting good advice. Here is a perfect example of what we are talking about. Read more
Read More »With Diabetes, Symptoms Are Not Always as Expected
Male, 72 years of age, type 2, insulin requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of work day, glucose elevated much higher than he reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy, leukocyte esterase 2+, wbc >60 H, bacteria many (>50) H, RBC 3-10, H.
Read More »Dr. Richard Bergman, Part 2 – Insulin Resistance Risk Factors
Diabetes in Control publisher Steve Freed and Dr. Richard Bergman discuss who is insulin resistant and the risk factors for insulin resistance. Dr. Richard Bergman is the founder and director of the Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes. Dr. Bergman was awarded the Albert Renold Award at the American Diabetes Association's 75th Scientific Sessions in Boston for a career distinguished by outstanding achievements in the training and mentorship of diabetes research scientists, and in the facilitation of diabetes research.
Read More »Sweet Relief: Dr. Avni Mahiji Helps Patients with Diabetes Circumvent Holiday Health Hazards
How does one address holiday temptation without going overboard health-wise?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.